Vaccine-preventable infections in travellers abroad -- meningococcal disease

Willcox, Adrienne
December 2010
Primary Health Care;Dec2010, Vol. 20 Issue 10, p33
Academic Journal
This article offers an overview of the prevention of meningococcal infections in Great Britain. It highlights risks to British people who travel abroad. It discusses the need for vaccination to prevent the disease. In addition, the article advises travelers to understand how vaccines against meningococcal infections function.


Related Articles

  • Travel health update. Chiodini, Jane // Practice Nurse;7/20/2012, Vol. 42 Issue 11, p43 

    The article offers updates travel medicine in Great Britain as of July 20, 2012. The Department of Health (DH) announces the electronic publication of "Green Book" in the May 2012 issue of "Vaccine Update." Nimentrix from GlaxoSmithKline, a conjugate memingococcal vaccine, licensed from 12...

  • Meningococcal B disease: past, present and future. Willcox, Adrienne // Practice Nursing;Dec2011, Vol. 22 Issue 12, p650 

    No abstract available.

  • Men B to be added to childhood imms -- if price is right.  // Practice Nurse;4/18/2014, Vol. 44 Issue 4, p11 

    The article reports on the plans of Great Britain's Department of Health to include in the childhood vaccination programme Bexsero® vaccine, which was found by the Joint Committee on Vaccination and Immunisation(JCVI) to be effective in preventing meningococcal B (MenB) in infants. The...

  • Meningococcal disease. Lowth, Mary // Practice Nurse;2/21/2014, Vol. 44 Issue 2, p12 

    The article examines the pathology, behaviour, presentation, management and mystery of meningoccal disease. It notes that the disease remains one of those diagnoses that doctors are afraid of missing, but in its early stages, doctors may not recognise it. It also presents suggestions on what...

  • No evidence for political manipulation... Moxon, E. Richard; Black, Steven // BMJ: British Medical Journal;5/10/2014, Vol. 348 Issue 7957, p23 

    A letter to the editor is presented in response to the article "Introducing a New Group B Meningococcus Vaccine" by D. I. Isaacs and J. McVernon, which appeared in the 2014 issue.

  • Introducing a new group B meningococcus vaccine. Isaacs, David; McVernon, Jodie // BMJ: British Medical Journal;4/5/2014, Vol. 348 Issue 7952, p9 

    The authors discuss the introduction of the new group B meningococcus vaccine Bexsero which is also known as 4CMenB, and which is developed using a genomic based reverse vaccinology approach. Particular focus is given to the introduction of 4CMenB vaccine in Great Britain to inform the rest of...

  • Vaccinations to protect adolescents. Barry, Christopher // Clinical Advisor;May2013, Vol. 16 Issue 5, p32 

    The article presents questions and answers related to human papillomavirus (HPV) virus vaccinations including the vaccine-preventable diseases which adolescents are at higher risk for, the prevalence of HPV, and the connection between HPV and cancer.

  • Criteria for choosing hepatitis A vaccine. Driver, Carolyn // Practice Nursing;Sep2010, Vol. 21 Issue 9, p479 

    The article focuses on hepatitis A infection, considering hepatitis A vaccine for travellers. It states that hepatitis A infection is a worldwide disease caused by an enterovirus that can give rise to outbreaks when experienced in a non-immune group. It says that hepatitis A vaccine is advised...

  • Travel health update. Chiodini, Jane // Practice Nurse;3/14/2014, Vol. 44 Issue 3, p30 

    The article presents travel health information and advice for practice nurses in Great Britain. Announced is the availability of the travel advice leaflet and insurance details of the Colostomy Association. The discontinuation of quadrivalent polysaccharide vaccine ACWY Vax supply from July 2014...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics